Metarrestin’s Anti-Cancer Mechanism Mapped Through Network Pharmacology
A new network pharmacology study maps how the anti-metastatic drug metarrestin rewires cancer cell protein networks and identifies the cell-cycle ...
A new network pharmacology study maps how the anti-metastatic drug metarrestin rewires cancer cell protein networks and identifies the cell-cycle ...
A retrospective study of 89 patients finds that 18F-FDG PET/CT metabolic parameters, particularly SUVmax, are statistically associated with PD-L1 expression ...
A new integrated study finds the gut bacterium Veillonella enriched in advanced pancreatic cancer patients and provides functional and genetic ...
A new meta-analysis of 27 studies finds that lung nodules in breast cancer patients are most often primary lung cancer ...
A study of 142 Turkish children with cancer finds that difficulty identifying and describing emotions is independently linked to higher ...
A prospective single-center trial found that a standardized enhanced recovery pathway after gastrectomy achieved high adherence, short hospital stays, and ...
A nationwide cohort of 410 patients shows zanubrutinib delivers high progression-free survival in CLL/SLL, with dose reductions and switches between ...
A five-gene plasma cfDNA methylation assay detected colorectal cancer with substantially higher sensitivity than CEA in a real-world cohort of ...
A Japanese team shows that AI-assisted imaging and flow cytometry count circulating tumor cells in liver cancer with strong agreement, ...
Researchers have discovered that the microRNA miR-205-3p triggers inflammatory pyroptotic cell death in triple-negative breast cancer by repressing HSP90AB1, while ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine